← Back to Search

Other

Ischemic Preconditioning for Peripheral Arterial Disease

N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
presence of vascular disease with intermittent claudication
between ages of 18-80
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial found that IPC may improve walking distance in people with intermittent claudication.

Eligible Conditions
  • Peripheral Arterial Disease
  • Intermittent Claudication
  • Vascular Ischemia
  • Peripheral Vascular Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Peak walking time
Secondary outcome measures
Claudication onset time
Muscle Fatigue

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ischemic PreconditioningExperimental Treatment1 Intervention
A standard blood pressure cuff will be placed on the right or left thigh, depending on the affected side, to occlude blood flow. The cuff will be inflated to 225 mmHg to prevent blood flow. Each session will consist of 4 cycles of 5 minute IPC applications, followed by 5 minutes of reperfusion for a total of 35 minutes.
Group II: ControlPlacebo Group1 Intervention
The sham intervention protocol will be identical to the IPC protocol except blood flow to the affected leg is unchanged as cuff pressure will be raised to between the venous and diastolic pressures

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
604 Previous Clinical Trials
1,162,232 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
146 Patients Enrolled for Peripheral Arterial Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment available to elderly individuals in this research project?

"The requirements for this trial necessitate that participants must be within the 18 to 80 age bracket. Additionally, there are 47 trials catered specifically towards minors and 633 studies focused on patients from over 65 years of age."

Answered by AI

How do I determine if I meet the criteria for participating in this clinical trial?

"The eligibility criteria for this trial states that participants must suffer from intermittent claudication, and be between 18 to 80 years old. In total, 24 individuals are needed to take part in the clinical study."

Answered by AI

Are there vacancies available for individuals to participate in this experiment?

"Clinicaltrials.gov affirms that this clinical trial is no longer recruiting participants, despite having originally been posted on June 14th 2018 and last updated October 14th 2021. Fortunately, there are 673 other medical trials available at the present time with active recruitment procedures underway."

Answered by AI
~4 spots leftby Mar 2025